Application no. and date | 19151147.6 (espacenet) (Federated) (European Patent Register), 20140731 | Patent/reg. no. and date | DK/EP 3708583, 20220302 | Publication date | 20200916 | Priority no. and date | US 201361861198 P, 20130801, US 201361901732 P, 20131108, US 201461933632 P, 20140130 | EP pub. no. and date |
EP 3708583 20200916 | Effective date | | Applicant/owner | Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | Applicant ref. no. | 1625619 | Inventor | HAMBLETON, Julie, Five Prime Therapeutics, Inc. 111 Oyster Point Boulevard
South San Francisco, CA 94080, US, HARDING, Thomas, Five Prime Therapeutics, Inc. 111 Oyster Point Boulevard
South San Francisco, CA 94080, US, PIERCE, Kristen, Five Prime Therapeutics, Inc. 111 Oyster Point Boulevard
South San Francisco, CA 94080, US, PATIL, Namrata, Five Prime Therapeutics, Inc. 111 Oyster Point Boulevard
South San Francisco, CA 94080, US, BRENNAN, Thomas, Five Prime Therapeutics, Inc. 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61K 31/513 (2006.01) , A61K 33/24 (2019.01) , A61K 39/395 (2006.01) , A61P 1/00 (2006.01) , A61P 43/00 (2006.01) , C07K 16/28 (2006.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) | Title | IKKE-FUCOSYLEREDE ANTI-FGFR2IIIB-ANTISTOFFER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|